Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Operating Expenses | 111 | 73 | 526 | 260 | 119 |
| Operating Income | -111 | -73 | -526 | -260 | -119 |
| Other Income | -279 | 9 | 698 | -722 | 3 |
| Pre-tax Income | -391 | -64 | 172 | -982 | -116 |
| Net Income Continuous | -391 | -64 | 172 | -982 | -116 |
| Net Income | $-391 | $-64 | $172 | $-982 | $-116 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.01 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.01 | -0.01 | N/A |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | N/A |
| EBITDA(a) | $-111 | $-73 | $-526 | $-260 | $-119 |